Related Experiment Video

Updated: Jun 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Optimal management of chronic graft-versus-host disease in children

David A Jacobsohn1

  • 1Children's National Medical Center, Washington, DC 20010, USA. djacobso@cnmc.org

British Journal of Haematology
|June 18, 2010
PubMed

Insights

Chronic graft-versus-host disease (GVHD) significantly impacts children post-haematopoietic stem cell transplantation (HSCT), causing mortality and morbidity. This review focuses on paediatric GVHD incidence, symptoms, and treatments.

Area of Science:

  • Hematology
  • Immunology
  • Pediatric Oncology

Background:

  • Allogeneic haematopoietic stem cell transplantation (HSCT) can lead to chronic graft-versus-host disease (GVHD).
  • Chronic GVHD is a leading cause of mortality and significant morbidity in HSCT survivors.
  • Existing literature predominantly focuses on adult chronic GVHD, with limited data on paediatric populations.

Purpose of the Study:

  • To review the incidence, clinical manifestations, and therapeutic strategies for chronic GVHD.
  • To specifically address the unique aspects and implications of chronic GVHD in children.
  • To provide a comprehensive overview relevant to the paediatric population undergoing HSCT.

Main Methods:

  • Systematic literature review.
  • Analysis of existing studies on chronic GVHD.
  • Focus on paediatric-specific data regarding incidence, presentation, and treatment outcomes.

Main Results:

  • Chronic GVHD presents unique challenges in children due to their long-term prognosis.
  • Incidence and manifestations may differ between paediatric and adult populations.
  • Therapeutic approaches require careful consideration for long-term effects in paediatric survivors.

Conclusions:

  • Chronic GVHD is a critical concern in paediatric HSCT, impacting long-term survival and quality of life.
  • Further research and tailored treatment strategies are needed for paediatric chronic GVHD.
  • Understanding paediatric-specific chronic GVHD is essential for improving outcomes in young HSCT recipients.

More Related Videos

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...